Matches in SemOpenAlex for { <https://semopenalex.org/work/W3118602263> ?p ?o ?g. }
- W3118602263 endingPage "22" @default.
- W3118602263 startingPage "22" @default.
- W3118602263 abstract "Foot-and-mouth disease virus (FMDV) causes a highly contagious and devastating disease in livestock animals and has a great potential to cause severe economic loss worldwide. The major antigen of FMDV capsid protein, VP1, contains the major B-cell epitope responsible for effectively eliciting protective humoral immunity. In this study, irradiated Salmonella Typhimurium (KST0666) were used as transgenic vectors containing stress-inducible plasmid pRECN-VP1 to deliver the VP1 protein from FMDV-type A/WH/CHA/09. Mice were orally inoculated with ATOMASal-L3 harboring pRECN-VP1, and FMDV virus-like particles, where (VLPFMDV)-specific humoral, mucosal, and cellular immune responses were evaluated. Mice vaccinated with attenuated Salmonella (KST0666) expressing VP1 (named KST0669) showed high levels of VLP-specific IgA in feces and IgG in serum, with high FMDV neutralization titer. Moreover, KST0669-vaccinated mice showed increased population of IFN-γ (type 1 T helper cells; Th1 cells)-, IL-5 (Th2 cells)-, and IL-17A (Th17 cells)-expressing CD4+ as well as activated CD8+ T cells (IFN-γ+CD8+ cells), detected by stimulating VLPFMDV. All data indicate that our Salmonella vector system successfully delivered FMDV VP1 to immune cells and that the humoral and cellular efficacy of the vaccine can be easily evaluated using VLPFMDV in a Biosafety Level I (BSL1) laboratory." @default.
- W3118602263 created "2021-01-18" @default.
- W3118602263 creator A5036907897 @default.
- W3118602263 creator A5042612360 @default.
- W3118602263 creator A5052407989 @default.
- W3118602263 creator A5056005181 @default.
- W3118602263 creator A5056395040 @default.
- W3118602263 creator A5068492828 @default.
- W3118602263 creator A5090968323 @default.
- W3118602263 date "2021-01-05" @default.
- W3118602263 modified "2023-09-27" @default.
- W3118602263 title "Salmonella Vaccine Vector System for Foot-and-Mouth Disease Virus and Evaluation of Its Efficacy with Virus-Like Particles" @default.
- W3118602263 cites W1753210683 @default.
- W3118602263 cites W1867168237 @default.
- W3118602263 cites W1938034723 @default.
- W3118602263 cites W1967725603 @default.
- W3118602263 cites W1970491106 @default.
- W3118602263 cites W1983724558 @default.
- W3118602263 cites W1997476182 @default.
- W3118602263 cites W2021955255 @default.
- W3118602263 cites W2034254323 @default.
- W3118602263 cites W2038352547 @default.
- W3118602263 cites W2045905629 @default.
- W3118602263 cites W2048174867 @default.
- W3118602263 cites W2053492374 @default.
- W3118602263 cites W2054600278 @default.
- W3118602263 cites W2061354183 @default.
- W3118602263 cites W2070265035 @default.
- W3118602263 cites W2074190930 @default.
- W3118602263 cites W2084487943 @default.
- W3118602263 cites W2085082874 @default.
- W3118602263 cites W2092311308 @default.
- W3118602263 cites W2095767765 @default.
- W3118602263 cites W2097081437 @default.
- W3118602263 cites W2097159629 @default.
- W3118602263 cites W2099362475 @default.
- W3118602263 cites W2103738533 @default.
- W3118602263 cites W2107277218 @default.
- W3118602263 cites W2127481417 @default.
- W3118602263 cites W2133129328 @default.
- W3118602263 cites W2139026373 @default.
- W3118602263 cites W2142941360 @default.
- W3118602263 cites W2149891813 @default.
- W3118602263 cites W2150321703 @default.
- W3118602263 cites W2166603124 @default.
- W3118602263 cites W2184473236 @default.
- W3118602263 cites W2185619964 @default.
- W3118602263 cites W2216203568 @default.
- W3118602263 cites W2289560291 @default.
- W3118602263 cites W2324228265 @default.
- W3118602263 cites W2326378498 @default.
- W3118602263 cites W2330272288 @default.
- W3118602263 cites W2409055882 @default.
- W3118602263 cites W2474674566 @default.
- W3118602263 cites W2496541927 @default.
- W3118602263 cites W2564714357 @default.
- W3118602263 cites W2760913892 @default.
- W3118602263 cites W2779187824 @default.
- W3118602263 cites W2889507854 @default.
- W3118602263 cites W2911214983 @default.
- W3118602263 cites W2927581596 @default.
- W3118602263 cites W2945976554 @default.
- W3118602263 cites W2990170458 @default.
- W3118602263 cites W3010479952 @default.
- W3118602263 cites W3036481947 @default.
- W3118602263 cites W3043621662 @default.
- W3118602263 cites W3044668367 @default.
- W3118602263 cites W3083648538 @default.
- W3118602263 cites W3092842475 @default.
- W3118602263 cites W3094809382 @default.
- W3118602263 cites W3094833440 @default.
- W3118602263 cites W3110134768 @default.
- W3118602263 cites W3112480332 @default.
- W3118602263 cites W4211223827 @default.
- W3118602263 doi "https://doi.org/10.3390/vaccines9010022" @default.
- W3118602263 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7824887" @default.
- W3118602263 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33466461" @default.
- W3118602263 hasPublicationYear "2021" @default.
- W3118602263 type Work @default.
- W3118602263 sameAs 3118602263 @default.
- W3118602263 citedByCount "2" @default.
- W3118602263 countsByYear W31186022632022 @default.
- W3118602263 countsByYear W31186022632023 @default.
- W3118602263 crossrefType "journal-article" @default.
- W3118602263 hasAuthorship W3118602263A5036907897 @default.
- W3118602263 hasAuthorship W3118602263A5042612360 @default.
- W3118602263 hasAuthorship W3118602263A5052407989 @default.
- W3118602263 hasAuthorship W3118602263A5056005181 @default.
- W3118602263 hasAuthorship W3118602263A5056395040 @default.
- W3118602263 hasAuthorship W3118602263A5068492828 @default.
- W3118602263 hasAuthorship W3118602263A5090968323 @default.
- W3118602263 hasBestOaLocation W31186022631 @default.
- W3118602263 hasConcept C147483822 @default.
- W3118602263 hasConcept C159047783 @default.
- W3118602263 hasConcept C167672396 @default.
- W3118602263 hasConcept C195616568 @default.
- W3118602263 hasConcept C203014093 @default.
- W3118602263 hasConcept C2522874641 @default.